Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 6 · 85.7%GRADE not reported 0 · 0%Very low 1 · 14.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Continuous glucose monitoring system vs intermittent modalities

Cerebral palsy ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Continuous glucose monitoring system vs intermittent modalities

Significant mental developmental delay ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Continuous glucose monitoring system vs intermittent modalities

Legal blindness ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Continuous glucose monitoring system vs intermittent modalities

Hearing deficit ‐ not measured · infants at risk of hypoglycaemia or hyperglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Continuous glucose monitoring system vs intermittent modalities

Neurodevelopmental impairment (composite outcome) ‐ not measured · infants at risk of hypoglycaemia or hyperglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Continuous glucose monitoring system vs intermittent modalities

All‐cause mortality during initial hospitalization ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia

It is very uncertain whether summary of findings table ‐ Continuous glucose monitoring (CGM) changes death during initial hospitalization (all‐cause mortality) compared with intermittent modalities (very low certainty).

1 finding from 1 review

Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants 2021 · Cochrane Headline outcomes only
RR 0.59 [0.16, 2.13]
2 studies · 230 participants
Very low

Continuous glucose monitoring system vs intermittent modalities

Neonatal seizures ‐ not reported · infants at risk of hypoglycaemia or hyperglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found